Melanocortin subtype-2 receptor (mc2r) antagonists and uses thereof
US-2026055082-A1 · Feb 26, 2026 · US
Crinetics Pharmaceuticals Inc holds 85 patents in our database, with recent filings and technology areas summarized below.
| Metric | Value |
|---|---|
| Total patents | 85 |
| Recent patents | 28 |
| First publication | Jan 5, 2017 |
| Latest publication | Feb 26, 2026 |
Year-over-year patent counts for this assignee.
Latest publications where this party is an assignee.
US-2026055082-A1 · Feb 26, 2026 · US
US-2026007758-A1 · Jan 8, 2026 · US
US-2026008767-A1 · Jan 8, 2026 · US
US-12492181-B2 · Dec 9, 2025 · US
US-2025367190-A1 · Dec 4, 2025 · US
Representative or frequently cited publications from precomputed assignee stats.
US-2026055082-A1 · Feb 26, 2026 · US
US-2026007758-A1 · Jan 8, 2026 · US
US-2026008767-A1 · Jan 8, 2026 · US
US-12492181-B2 · Dec 9, 2025 · US
US-2025367190-A1 · Dec 4, 2025 · US
Mapped technology topics for this assignee.
| Technology | Patents |
|---|---|
| Human Necessities | 83 |
| Chemistry & Metallurgy | 70 |
| Physics | 2 |
| Cross-Sectional Technologies | 2 |
Answers are generated from the same data shown on this page.